Medtech panel says environment for IPOs remains strong

CEOs from Entellus Medical and Nevro share their experiences with going public

With 2014 a rebounding year for medical device and biopharmaceutical IPOs, 2015 should build further on that progress, a panel at the MedTech Investing Conference said this week.

Entellus Medical Inc., Nevro Corp., Piper Jaffray

News Well, Initial Public Offering (IPO)

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1P6u7Sn